None
Quote | Orphazyme A S (OTCMKTS:OZYMF)
Last: | $0.09 |
---|---|
Change Percent: | 0.0% |
Open: | $0.091 |
Close: | $0.09 |
High: | $0.091 |
Low: | $0.09 |
Volume: | 3,250 |
Last Trade Date Time: | 12/05/2023 03:00:00 am |
News | Orphazyme A S (OTCMKTS:OZYMF)
2024-03-12 14:42:36 ET More on Zevra Therapeutics Zevra Therapeutics appoints Adrian Quartel as CMO Zevra seeks FDA nod for rare disease therapy arimoclomol Seeking Alpha’s Quant Rating on Zevra Therapeutics Historical earnings data for Zevra Therapeut...
Message Board Posts | Orphazyme A S (OTCMKTS:OZYMF)
Subject | By | Source | When |
---|---|---|---|
Not double down? | Richard Perry | investorshub | 03/11/2022 12:45:48 PM |
Now what | Richard Perry | investorshub | 03/11/2022 11:35:24 AM |
https://www.clinicaltrialsarena.com/comment/orphazymes-arimoclomol-expected-to-b | Lazybones2 | investorshub | 10/14/2021 7:45:53 PM |
https://www.fda.gov/news-events/press-announcements/fda-awards-18-grants-stimula | Lazybones2 | investorshub | 10/14/2021 7:43:39 PM |
https://www.fda.gov/news-events/press-announcements/fda-awards-18-grants-stimula | Lazybones2 | investorshub | 10/14/2021 7:43:35 PM |